Market Research Logo

United States Pharmaceuticals & Healthcare Q1 2019

United States Pharmaceuticals & Healthcare Q1 2019

Key View:

The outcome of the November 2018 midterm elections reduces the prospect of new legislation targeting high drugprices. This is a moderately positive outcome for pharmaceutical companies, which have been under pressure from PresidentTrump to lower costs for patients. Nevertheless, due to widespread concern among politicians and the public, high drug prices willbe the major issue in the US pharmaceutical market in 2019.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
United States Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Amgen
AstraZeneca
Eli Lilly
GlaxoSmithKline
Merck & Co
Pfizer
United States Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report